APPENDIX I

China

ACCOUNTANTS’ REPORT

BeiGene Beijing, BeiGene Suzhou, BeiGene Shanghai, BeiGene Biologics, BeiGene Guangzhou
Factory, BeiGene Guangzhou and BeiGene Pharmaceutical (Shanghai) are subject to the statutory tax
rate of 25% in accordance with the EIT Law, which was effective since January 1, 2008. Under the
EIT Law, all enterprises are subject to the 25% enterprise income tax rate, except for certain entities
that enjoy the tax holidays or preferential
tax treatments. Under the EIT Law and its relevant
regulations, dividends paid by China enterprises out of profits earned post-2007 to non-China tax
resident investors are subject to China withholding tax of 10%. A lower withholding tax rate may be
applied based on applicable tax treaty with certain jurisdictions.

Australia

BeiGene AUS Pty Ltd., incorporated in Australia is subject to corporate income tax at a rate of
30%. BeiGene AUS Pty Ltd. had no taxable income for all periods presented and therefore, no
provision for income taxes was required.

United States

BeiGene (USA), which was incorporated in Delaware, the United States on July 8, 2015, was
subject to statutory U.S. Federal corporate income tax at a rate of 35% for the years ended December
31, 2016 and 2017, and 35% and 21% for the three months ended March 31, 2017 and 2018. BeiGene
(USA) was also subject to the state income tax in New Jersey, California and Massachusetts, at a rate
of 9.0%, 8.8% and 8.0%, respectively, during the Relevant Periods.

Switzerland

BeiGene Switzerland, incorporated in Switzerland on September 1, 2017, is subject to corporate
income tax at a rate of approximately 10.0%. BeiGene Switzerland had no taxable income for year
ended December 31, 2017 and the three months ended March 31, 2018, and therefore, no provision for
income taxes was required.

The components of income (loss) before income taxes are as follows:

Year ended December 31,

Three months ended March 31,

2016

US$’000

2017

US$’000

2017

US$’000

(Unaudited)

2018

US$’000

PRC ..............................................
U.S. ..............................................
Others ...........................................

Total .............................................

(7,352)
678
(112,489)

(119,163)

(49,970)
6,928
(22,095)

(65,137)

(4,116)
3,043
(49,370)

(50,443)

(29,519)
2,754
(81,763)

(108,528)

— I-49 —

